(Q50654264)
Statements
Intranasal desmopressin as an adjunct to risperidone for negative symptoms of schizophrenia: a randomized, double-blind, placebo-controlled, clinical trial. (English)
1 reference
1 reference
1 reference
Seyed Mohammad Reza Hosseini
1 reference
Mehdi Farokhnia
1 reference
Farzin Rezaei
1 reference
Amirhossein Gougol
1 reference
Habibeh Yekehtaz
1 reference
Negar Iranpour
1 reference
Mina Tabrizi
1 reference
Ali Ghaleiha
1 reference
25 February 2014
1 reference
24
1 reference
6
1 reference
846-855
1 reference
Identifiers
1 reference